D. E. Shaw & Co., Inc. Singular Genomics Systems, Inc. Transaction History

D. E. Shaw & Co., Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.37 - $0.99 $3,958 - $10,592	10,699 Added 26.26%	51,441 $19,000
Q2 2023 Aug 14, 2023	BUY	$0.78 - $1.28 $5,189 - $8,515	6,653 Added 19.52%	40,742 $33,000
Q1 2023 May 15, 2023	SELL	$1.1 - $2.95 $13,137 - $35,231	-11,943 Reduced 25.94%	34,089 $41,000
Q4 2022 Feb 14, 2023	BUY	$1.82 - $2.71 $11,056 - $16,463	6,075 Added 15.2%	46,032 $92,000
Q3 2022 Nov 14, 2022	SELL	$2.5 - $4.73 $450,137 - $851,660	-180,055 Reduced 81.84%	39,957 $100,000
Q2 2022 Aug 15, 2022	SELL	$2.86 - $6.44 $115,541 - $260,169	-40,399 Reduced 15.51%	220,012 $840,000
Q1 2022 May 16, 2022	BUY	$5.94 - $12.09 $1.22 Million - $2.47 Million	204,629 Added 366.84%	260,411 $1.64 Million
Q4 2021 Feb 14, 2022	BUY	$10.45 - $16.9 $241,457 - $390,491	23,106 Added 70.71%	55,782 $645,000
Q3 2021 Nov 15, 2021	BUY	$10.9 - $27.63 $356,168 - $902,837	32,676 New	32,676 $366,000

1.43M

Ticker OMIC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 71,193,296
Market Cap $1.42B
Description
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associat...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.